Division of Infectious Diseases and Immunology, CSIR-Indian Institute of Chemical Biology, Kolkata, West Bengal, India.
Department of Zoology, Cooch Behar Panchanan Barma University, Cooch Behar, West Bengal, India.
Br J Pharmacol. 2023 Sep;180(18):2317-2340. doi: 10.1111/bph.16070. Epub 2023 May 16.
Mitochondrial oxidative stress, inflammation and apoptosis primarily underlie gastric mucosal injury caused by the widely used non-steroidal anti-inflammatory drugs (NSAIDs). Alternative gastroprotective strategies are therefore needed. Sirtuin-3 pivotally maintains mitochondrial structural integrity and metabolism while preventing oxidative stress; however, its relevance to gastric injury was never explored. Here, we have investigated whether and how sirtuin-3 stimulation by the phytochemical, honokiol, could rescue NSAID-induced gastric injury.
Gastric injury in rats induced by indomethacin was used to assess the effects of honokiol. Next-generation sequencing-based transcriptomics followed by functional validation identified the gastroprotective function of sirtuin-3. Flow cytometry, immunoblotting, qRT-PCR and immunohistochemistry were used measure effects on oxidative stress, mitochondrial dynamics, electron transport chain function, and markers of inflammation and apoptosis. Sirtuin-3 deacetylase activity was also estimated and gastric luminal pH was measured.
Indomethacin down-regulated sirtuin-3 to induce oxidative stress, mitochondrial hyperacetylation, 8-oxoguanine DNA glycosylase 1 depletion, mitochondrial DNA damage, respiratory chain defect and mitochondrial fragmentation leading to severe mucosal injury. Indomethacin dose-dependently inhibited sirtuin-3 deacetylase activity. Honokiol prevented mitochondrial oxidative damage and inflammatory tissue injury by attenuating indomethacin-induced depletion of both sirtuin-3 and its transcriptional regulators PGC1α and ERRα. Honokiol also accelerated gastric wound healing but did not alter gastric acid secretion, unlike lansoprazole.
Sirtuin-3 stimulation by honokiol prevented and reversed NSAID-induced gastric injury through maintaining mitochondrial integrity. Honokiol did not affect gastric acid secretion. Sirtuin-3 stimulation by honokiol may be utilized as a mitochondria-based, acid-independent novel gastroprotective strategy against NSAIDs.
广泛使用的非甾体抗炎药(NSAIDs)会导致胃黏膜损伤,其主要原因是线粒体氧化应激、炎症和细胞凋亡。因此,需要替代的胃保护策略。Sirtuin-3 可以维持线粒体的结构完整性和代谢,同时防止氧化应激;然而,其与胃损伤的关系从未被探索过。在这里,我们研究了植物化学物质厚朴酚通过刺激 Sirtuin-3 是否以及如何拯救 NSAID 引起的胃损伤。
使用吲哚美辛诱导大鼠胃损伤来评估厚朴酚的作用。基于下一代测序的转录组学研究结合功能验证,确定了 Sirtuin-3 的胃保护功能。流式细胞术、免疫印迹、qRT-PCR 和免疫组织化学用于测量对氧化应激、线粒体动力学、电子传递链功能以及炎症和细胞凋亡标志物的影响。还估计了 Sirtuin-3 的去乙酰化酶活性并测量了胃腔 pH 值。
吲哚美辛下调 Sirtuin-3 以诱导氧化应激、线粒体过度乙酰化、8-氧鸟嘌呤 DNA 糖基化酶 1 耗竭、线粒体 DNA 损伤、呼吸链缺陷和线粒体碎片化,导致严重的黏膜损伤。吲哚美辛剂量依赖性地抑制 Sirtuin-3 的去乙酰化酶活性。厚朴酚通过减弱吲哚美辛诱导的 Sirtuin-3 及其转录调节剂 PGC1α 和 ERRα 的耗竭,预防线粒体氧化损伤和炎症组织损伤。厚朴酚还加速了胃的伤口愈合,但与兰索拉唑不同,它并没有改变胃酸分泌。
厚朴酚通过维持线粒体完整性来预防和逆转 NSAID 引起的胃损伤。厚朴酚不影响胃酸分泌。厚朴酚刺激 Sirtuin-3 可能作为一种基于线粒体的、与酸无关的新型 NSAIDs 胃保护策略被利用。